Manufacturing considerations underpinning viral & non-viral platform selection

Cell & Gene Therapy Insights 2022; 8(11), 1497.

DOI: 10.18609/cgti.2022.218

Published: 15 December 2022
Poster
Allison Hagerman, Aaron Noyes, Vladimir Slepushkin, Laurens Sierkstra


Cell & Gene Therapy Insights brought together a panel of industry experts to discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies. Here are some of the highlights…